211 results
8-K
EX-99.1
ACET
Adicet Bio Inc
14 May 24
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
4:03pm
, business operations, employee hiring and retention, and
ability to raise additional capital; Adicet’s ability to execute on its strategy including
DEFR14A
ACET
Adicet Bio Inc
26 Apr 24
Revised proxy
4:13pm
the employees, officers, non-employee directors and consultants of the Company and its subsidiaries upon whose judgment, initiative and efforts we largely … of the Compensation Committee in granting stock options and other awards to the Company’s employees, non-employee directors and other key persons
8-K
EX-99.1
ACET
Adicet Bio Inc
22 Apr 24
Regulation FD Disclosure
4:31pm
to disruptions to our preclinical and clinical studies, business operations, employee hiring and retention, and ability to raise additional capital
8-K
any0zltqjul9c9i c3
22 Apr 24
Regulation FD Disclosure
4:31pm
PRE 14A
504u4rjplm shd
12 Apr 24
Preliminary proxy
5:23pm
8-K
EX-1.1
4wa6pn
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
424B5
vkn43knt08fycj8u6yg
22 Mar 24
Prospectus supplement for primary offering
4:12pm
S-8 POS
fi3k7nrnschfxf98s11
19 Mar 24
Registration of securities for employees (post-effective amendment)
4:24pm
S-8
pf2 qz8lnk04ptg
19 Mar 24
Registration of securities for employees
4:20pm
S-8
ew5qpxnhr75
19 Mar 24
Registration of securities for employees
4:20pm
S-8
EX-5.1
7fmzylh 0stvf6ied17a
19 Mar 24
Registration of securities for employees
4:20pm
8-K
EX-99.1
fiip2 ihhwf
19 Mar 24
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
4:13pm
8-K
EX-1.1
opi1 h54xitgsc7
24 Jan 24
Adicet Bio, Inc. Announces Proposed Public Offering
4:34pm
424B5
tucwrk
24 Jan 24
Prospectus supplement for primary offering
4:32pm
424B5
xvf43g38h
22 Jan 24
Prospectus supplement for primary offering
4:30pm